B 251 (Phenazopyridine Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)
Pill with imprint B 251 is Brown, Elliptical / Oval and has been identified as Phenazopyridine plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Butabarbital/hyoscyamine/phenazopyridine is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. Butabarbital/hyoscyamine/phenazopyridine butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B 251
- B 251
- butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
More about butabarbital/hyoscyamine/phenazopyridine
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: urinary antispasmodics
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.